Doctors question evidence behind Pentagon plan for testosterone screening

US Defense Secretary Pete Hegseth has ordered annual testosterone screening for active-duty and reserve service members aged 30 and older, aiming to improve military readiness. However, many medical professionals question the scientific basis for this plan, warning it could lead to unnecessary or harmful treatments, including infertility. Experts note that current medical guidelines recommend testosterone supplementation only for symptomatic individuals with confirmed deficiency, not for widespread screening based on age alone. Concerns are also raised about potential side effects of testosterone therapy, such as fertility issues, blood thickening, and mood volatility. The mandate is part of broader healthcare policy changes implemented by Hegseth that have drawn expert debate.

US Defense Secretary Pete Hegseth announced a new annual testosterone screening program for service members aged 30 and over, starting this year. This screening will be integrated into the mandatory annual health assessment for those 30 and older, with younger members able to opt in. Hegseth stated the initiative aims to "restore and optimize" troops' natural capabilities and ensure they have the biological foundation to sustain combat. The program is part of broader efforts to maintain the military's advantage through the "individual warfighter" and physical standards. This move follows a provision in the Fiscal Year 2025 National Defense Authorization Act requiring a briefing on low testosterone treatments and existing protocols.

US Defence Secretary Pete Hegseth announced a new annual screening program for "testosterone deficiency" among troops, aimed at ensuring they operate at their "absolute best." The screenings will be mandatory for service members aged 30 and older, with those under 30 able to volunteer. Hegseth stated that any resulting testosterone replacement therapy would be voluntary. The Pentagon cited the need to keep troops "strong, resilient and capable" and to maintain "maximum psychological and mental readiness" for the demands of the modern battlefield as reasons for the policy. The initiative aligns with broader advocacy within the Trump administration for increased access to testosterone replacement therapies.

US Defense Secretary Pete Hegseth announced a new Department of Defense screening program for testosterone deficiency. Starting Wednesday, soldiers aged 30 and older will undergo annual tests as part of their health assessments to ensure they have optimal testosterone levels for peak performance. Those under 30 can opt in to the screening. The program aims to support service members' physical and mental readiness for combat and promote long-term health. Treatment, including testosterone replacement therapy, will be voluntary and focused on restoring natural capabilities. Hegseth stated the initiative is part of the department's commitment to providing elite medical care.